July 28, 2016 1:14 PM ET

Biotechnology

Company Overview of Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L.

Company Overview

As of December 6, 2012, Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L. was acquired by Sygnis AG, in a reverse merger transaction. SYGNIS Pharma AG, a specialty pharmaceutical company, focuses on the research and development of therapies for the treatment of central nervous system disorders. Its products under development include AX200, a biological molecule, which is in Phase II clinical trials for the treatment of acute ischemic stroke; and KIBRA, which is in pre-clinical stage for the treatment of various forms of dementia. The company was formerly known as LION bioscience AG and changed its name to SYGNIS Pharma AG in January 2007. SYGNIS Pharma AG was founded in 1997 ...

Im Neuenheimer Feld 515

Heidelberg,  69120

Germany

Founded in 1997

21 Employees

Phone:

49 6221 454 6

Fax:

49 6221 454 700

Key Executives for Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L.

Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L. does not have any Key Executives recorded.

Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L. Key Developments

Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L. to Report Q2, 2016 Results on Nov 06, 2015

Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L. announced that they will report Q2, 2016 results on Nov 06, 2015

Similar Private Companies By Industry

Company Name Region
µ-bond GmbH Europe
4 Animals AlsterScience GmbH Europe
Across Barriers GmbH Europe
Actinodrug Pharmaceuticals GmbH Europe
ACTIPAC Biosystems GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sygnis Pharma AG, Prior to Reverse Merger with X-Pol Biotech S.L., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.